“…For triphasic scaffolds, the middle phase is treated as a discrete layer with intermediate properties between bone and cartilage. , Often, “middle-ground” levels (between bone and cartilage) of scaffold porosity, − modulus, ,,, and material composition , are used to create a transition. Successful in vitro indications often show chondrocytic proliferation in a mineralized environment and expression phenotypical of hypertrophic chondrocytes, similar to that of the calcified cartilage layer. , Examples of these strategies include diverse composites (e.g., agarose with HAp, organic sol gel-coated calcium polyphosphate), , scaffold component orientations (e.g., arrayed platelike HAp), additives for osteochondral differentiation (e.g., Mg-doped wollastonite, icariin, or zinc oxide), − or components that promote a proregenerative environment (e.g., strontium or copper). , …”